Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines

A caller oral vaccine level utilizing genetically engineered Bifidobacterium could heighten anti-tumor immunity. In an exploratory Phase I objective study, the vaccine was good tolerated and generated immunologic and objective findings that warrant further investigation. The results besides constituent to imaginable biomarkers that whitethorn assistance place patients astir apt to payment from this approach.